Drugs / CG7870
last change Aug 2004 re-read 3 minutes ago

CG7870

Developed for
prostate cancer
Investigated by
Cell Genesys

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00103428 Aug 2004 → ? prostate cancer Cell Genesys Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CG7870 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00103428 ↗
Route Intravenous “receive treatment intravenously with CG7870” NCT00103428 ↗